Article
PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer
2020-08-07
Abstract excerpt
<h4>ABSTRACT</h4> Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades. Contributing factors to metastatic spread include the maintenance and expansion of breast cancer stem cells (CSCs). Breast CSCs frequently exist as...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 14acfb4b-dd52-5a00-ae2b-6c17d60b9216
- DOI
- 10.1101/2020.08.07.238550
